newsfilter
← Latest News
Business Wire·

ImmunoPrecise Antibodies (IPA) Announces Completion of At-the-Market Equity Offering and Full Conversion of Yorkville Debenture

IPA Successfully Executes Strategic Capital Initiatives, Strengthening Financial Position for Growth ImmunoPrecise Antibodies Ltd. ("IPA" or the "Company") (NASDAQ:IPA), a leader in AI-driven antibody discovery and